Optimi Health Provides Progress Report On Year Of Commercialization
September 01, 2022 09:00 ET
|
Optimi Health Corp.
Company set to introduce psychedelic product catalogue showcasing in-house EU-GMP manufacturing expertise VANCOUVER, British Columbia, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE:...
Optimi Health Enters Into International Collaborative Research and Supply Agreement With Promises Innovative Recovery Center
August 30, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health...
Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for Functional Mushroom Supplements and Appoints Chief Financial Officer to its Board of Directors
August 25, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health...
Galexxy Holdings Announces its Strategic Alliance and Purchase Option to Acquire eVendco Inc.
August 24, 2022 09:00 ET
|
Galexxy Holdings Inc.
Newport Beach, CALIFORNIA, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Galexxy Holdings Inc., (“Galexxy”) (OTC: GXXY) is pleased to announce that its recently acquired subsidiary, Wellbeing Farms LLC., (WBF)...
Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health
August 16, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health...
Galexxy Holdings Appoints a New Chairman and CEO
August 15, 2022 09:00 ET
|
Galexxy Holdings Inc.
Newport Beach, CALIFORNIA, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Galexxy Holdings Incorporated ("Galexxy" or "the Company") (OTC: GXXY) is pleased to announce that following its recent acquisition of...
Galexxy Holdings Finalizes its Acquisition Of WellBeing Farms LLC
August 04, 2022 09:00 ET
|
Galexxy Holdings Inc.
Newport Beach, CALIFORNIA, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Galexxy Holdings Inc., (“Galexxy,” “GXXY”) (OTC: GXXY) is pleased to announce that it has finalized the acquisition of WellBeing Farms...
Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs
July 19, 2022 07:00 ET
|
Mydecine Innovations Group Inc.
DENVER, July 19, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the...
Optimi Health Finalizes Psilocybin Supply Agreement With Bloom Psychedelic Therapy And Research Centre
July 13, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company cultivating and...
Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA
June 28, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 28, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...